ArticleEMBO molecular medicine2019

Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.

Maksymilian Prondzynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.